Merus N.V.
MRUSNASDAQHealthcare
$90.00
+$0.00(+0.00%)
Market Cap$6.8B
P/E Ratio—
52W High$97.14
52W Low$33.19
Merus N.V. (MRUS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MRUS · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2025Report Date: Oct 31, 2025EPS Actual
-$1.23
Est. -$1.23 · +0.0%
Revenue
$0.01B
Est. $0.01B · +15.8%
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Oct 31, 2025
After Market Close
▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
MRUS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2025 | Oct 31, 2025 | -$1.23 | -$1.23 | +0.0% | $0.01B | $0.01B | +15.8% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -$1.17 | -$2.23 | -90.6% | $0.01B | $0.01B | -10.1% |
| ▼ Q2 FY2025 | May 7, 2025 | -$1.16 | -$1.40 | -20.7% | $0.03B | $0.01B | +289.8% |
| ▲ Q1 FY2025 | Feb 27, 2025 | -$0.89 | -$0.41 | +53.9% | $0.01B | $0.01B | -10.5% |
| ▼ Q4 FY2024 | Oct 31, 2024 | -$0.90 | -$0.95 | -5.6% | $0.01B | $0.01B | +48.0% |
| ▼ Q3 FY2024 | Aug 1, 2024 | -$0.76 | -$0.81 | -6.6% | $0.01B | $0.01B | -7.1% |
| ▲ Q2 FY2024 | May 8, 2024 | -$0.81 | -$0.59 | +27.2% | $0.01B | $0.01B | -13.1% |
| ▼ Q1 FY2024 | Feb 28, 2024 | -$0.74 | -$1.04 | -40.5% | $0.01B | $0.01B | -3.0% |
Q4 FY2025
Oct 31, 2025
EPS Actual
-$1.23
EPS Est.
-$1.23
EPS Surpr.
+0.0%
Revenue
$0.01B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
-$2.23
EPS Est.
-$1.17
EPS Surpr.
-90.6%
Revenue
$0.01B
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$1.40
EPS Est.
-$1.16
EPS Surpr.
-20.7%
Revenue
$0.03B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
-$0.41
EPS Est.
-$0.89
EPS Surpr.
+53.9%
Revenue
$0.01B
Q4 FY2024
Oct 31, 2024Miss
EPS Actual
-$0.95
EPS Est.
-$0.90
EPS Surpr.
-5.6%
Revenue
$0.01B
Q3 FY2024
Aug 1, 2024Miss
EPS Actual
-$0.81
EPS Est.
-$0.76
EPS Surpr.
-6.6%
Revenue
$0.01B
Q2 FY2024
May 8, 2024Beat
EPS Actual
-$0.59
EPS Est.
-$0.81
EPS Surpr.
+27.2%
Revenue
$0.01B
Q1 FY2024
Feb 28, 2024Miss
EPS Actual
-$1.04
EPS Est.
-$0.74
EPS Surpr.
-40.5%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.95 | $-0.95 | $-0.95 | 1 |
| Q3 FY2027 | $-0.91 | $-0.91 | $-0.91 | 1 |
| Q2 FY2027 | $-0.88 | $-0.88 | $-0.88 | 1 |
| Q1 FY2027 | $-0.87 | $-0.87 | $-0.87 | 1 |
| Q4 FY2026 | $-1.34 | $-1.34 | $-1.34 | 1 |
| Q3 FY2026 | $-1.23 | $-1.23 | $-1.23 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2025 | Oct 31, 2025 | +0.0% | $95.06 | $94.86 | -0.21% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -90.6% | $66.93 | $67.45 | +0.78% |
| ▼ Q2 FY2025 | May 7, 2025 | -20.7% | $39.45 | $39.43 | -0.05% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +53.9% | $45.53 | $46.22 | +1.52% |
| ▼ Q4 FY2024 | Oct 31, 2024 | -5.6% | $51.28 | $49.93 | -2.63% |
| ▼ Q3 FY2024 | Aug 1, 2024 | -6.6% | $53.04 | $52.42 | -1.17% |
| ▲ Q2 FY2024 | May 8, 2024 | +27.2% | $48.73 | $47.09 | -3.37% |
| ▼ Q1 FY2024 | Feb 28, 2024 | -40.5% | $48.94 | $48.70 | -0.49% |
Q4 FY2025-0.21%
Report Date
Oct 31, 2025
EPS Beat/Miss
+0.0%
Price Before
$95.06
Price After
$94.86
Q3 FY2025+0.78%
Report Date
Aug 5, 2025
EPS Beat/Miss
-90.6%
Price Before
$66.93
Price After
$67.45
Q2 FY2025-0.05%
Report Date
May 7, 2025
EPS Beat/Miss
-20.7%
Price Before
$39.45
Price After
$39.43
Q1 FY2025+1.52%
Report Date
Feb 27, 2025
EPS Beat/Miss
+53.9%
Price Before
$45.53
Price After
$46.22
Q4 FY2024-2.63%
Report Date
Oct 31, 2024
EPS Beat/Miss
-5.6%
Price Before
$51.28
Price After
$49.93
Q3 FY2024-1.17%
Report Date
Aug 1, 2024
EPS Beat/Miss
-6.6%
Price Before
$53.04
Price After
$52.42
Q2 FY2024-3.37%
Report Date
May 8, 2024
EPS Beat/Miss
+27.2%
Price Before
$48.73
Price After
$47.09
Q1 FY2024-0.49%
Report Date
Feb 28, 2024
EPS Beat/Miss
-40.5%
Price Before
$48.94
Price After
$48.70
Avg Beat Reaction-0.69%
Avg Miss Reaction-0.71%
Beat Rate3 / 8 quarters
Largest Move-3.37% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MRUS ends December
Merus N.V. (MRUS) most recently reported earnings on October 31, 2025 for Q4 FY2025, posting EPS of $-1.23 (in line with the analyst consensus of $-1.23). The next MRUS earnings date is expected around September 1, 2026.
Each quarter, investors track MRUS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MRUS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MRUS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MRUS earnings · 4 questionsMerus N.V.'s next earnings report is expected around September 1, 2026. MRUS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MRUS historically reports after market close (AMC).
MRUS earnings datewhen is MRUS earningsMRUS next earnings datewhen does MRUS report earningsMRUS earnings calendar
▸ Source: FMP · Merus N.V. SEC filings · US GAAP · Merus N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026